Y-mAbs Therapeutics, Inc. (YMAB) Ownership

$4.70

$0.1 (-2.08%)
Last update: 04:00 PM EST
Day's range
$4.58
Day's range
$4.78

Y-mAbs Therapeutics, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
PARADIGM BIOCAPITAL ADVISORS LP 05/15/2025 4.24 M $18.77 M   0.00% 9.39%
05/19/2025 3.24 M $14.33 M   13.05% 7.17%
BLACKROCK, INC. 05/02/2025 2.90 M $12.86 M   -3.22% 6.43%
CALIGAN PARTNERS LP 05/15/2025 2.34 M $10.38 M   32.50% 5.19%
SOFINNOVA INVESTMENTS, INC. 05/15/2025 2.19 M $9.72 M   0.00% 4.86%
VANGUARD GROUP INC 05/09/2025 1.95 M $8.62 M   -2.68% 4.32%
POLAR CAPITAL HOLDINGS PLC 05/15/2025 1.83 M $8.11 M   0.00% 4.06%
GEODE CAPITAL MANAGEMENT, LLC 05/13/2025 849.50 K $3.76 M   3.31% 1.88%
STATE STREET CORP 05/15/2025 789.02 K $3.50 M   -39.97% 1.75%
BOOTHBAY FUND MANAGEMENT, LLC 05/15/2025 693.69 K $3.07 M   0.00% 1.54%
D. E. SHAW & CO., INC. 05/15/2025 549.67 K $2.44 M   -10.64% 1.22%
MORGAN STANLEY 05/15/2025 500.16 K $2.22 M   55.91% 1.11%
MILLENNIUM MANAGEMENT LLC 05/15/2025 466.62 K $2.07 M   1,216.39% 1.03%
PICTET ASSET MANAGEMENT HOLDING SA 05/05/2025 441.93 K $1.96 M   -41.57% 0.98%
DIMENSIONAL FUND ADVISORS LP 05/13/2025 418.55 K $1.86 M   -9.65% 0.93%
SOLEUS CAPITAL MANAGEMENT, L.P. 05/15/2025 349.98 K $1.55 M   0.00% 0.78%
NORTHERN TRUST CORP 05/13/2025 327.90 K $1.45 M   -8.72% 0.73%
BANK OF AMERICA CORP /DE/ 05/15/2025 282.32 K $1.25 M   122.02% 0.63%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/09/2025 277.61 K $1.23 M   -2.44% 0.62%
RENAISSANCE TECHNOLOGIES LLC 05/14/2025 256.71 K $1.14 M   95.07% 0.57%
JPMORGAN CHASE & CO 05/12/2025 247.44 K $1.10 M   153.37% 0.55%
JACOBS LEVY EQUITY MANAGEMENT, INC 05/15/2025 237.51 K $1.05 M   58.68% 0.53%
WELLINGTON MANAGEMENT GROUP LLP 05/13/2025 204.05 K $903.95 K   53.12% 0.45%
GOLDMAN SACHS GROUP INC 05/16/2025 201.78 K $893.87 K   -7.94% 0.45%
AQR CAPITAL MANAGEMENT LLC 05/15/2025 164.79 K $730.01 K   869.34% 0.37%
05/16/2025 155.53 K $688.99 K   0.00% 0.34%
CUBIST SYSTEMATIC STRATEGIES, LLC 05/15/2025 155.52 K $688.96 K   223.93% 0.34%
TWO SIGMA INVESTMENTS, LP 05/15/2025 154.79 K $685.70 K   75.22% 0.34%
CITADEL ADVISORS LLC 05/15/2025 153.96 K $682.02 K   -30.62% 0.34%
FEDERATED HERMES, INC. 05/08/2025 153.45 K $679.80 K   245.04% 0.34%
TWO SIGMA ADVISERS, LP 05/15/2025 143.30 K $634.82 K   93.91% 0.32%
STONEPINE CAPITAL MANAGEMENT, LLC 05/14/2025 131.16 K $581.04 K   100.00% 0.29%
SQUAREPOINT OPS LLC 05/15/2025 128.53 K $569.38 K   24.82% 0.29%
05/12/2025 112.48 K $498.30 K   100.00% 0.25%
RICE HALL JAMES & ASSOCIATES, LLC 05/01/2025 103.64 K $459.13 K   -4.52% 0.23%
BNP PARIBAS ARBITRAGE, SNC 05/14/2025 95.50 K $423.07 K   1,859.42% 0.21%
BANK OF NEW YORK MELLON CORP 04/29/2025 92.47 K $409.66 K   0.03% 0.21%
UBS GROUP AG 05/13/2025 91.58 K $405.68 K   135.22% 0.20%
XTX TOPCO LTD 05/08/2025 91.45 K $405.14 K   340.36% 0.20%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 05/14/2025 60.66 K $268.72 K   112.92% 0.13%
WESBANCO BANK INC 04/14/2025 55.00 K $243.65 K   100.00% 0.12%
ALLIANCEBERNSTEIN L.P. 05/15/2025 54.78 K $242.68 K   0.00% 0.12%
RHUMBLINE ADVISERS 05/29/2025 53.91 K $238.81 K   4.78% 0.12%
BARCLAYS PLC 05/15/2025 46.76 K $207.00 K   -38.36% 0.10%
SAPIENT CAPITAL LLC 04/15/2025 43.70 K $193.59 K   0.00% 0.10%
STRS OHIO 05/28/2025 43.40 K $192.26 K   0.00% 0.10%
QUEST PARTNERS LLC 05/14/2025 38.93 K $172.44 K   43.45% 0.09%
CITADEL ADVISORS LLC 05/15/2025 38.40 K $170.11 K   585.71% 0.09%
JUMP FINANCIAL, LLC 05/14/2025 38.08 K $168.69 K   14.08% 0.08%
VIRTUS INVESTMENT ADVISERS, INC. 05/15/2025 36.75 K $162.81 K   100.00% 0.08%

Y-mAbs Therapeutics, Inc. institutional Ownership - FAQ's

During the previous two years, 139 institutional investors and hedge funds held shares of Y-mAbs Therapeutics, Inc.. The most heavily invested institutionals were:

Paradigm Biocapital Advisors LP: 4.24 M

BlackRock, Inc.: 2.9 M

Caligan Partners LP: 2.34 M

Sofinnova Investments, Inc.: 2.19 M

VANGUARD GROUP INC: 1.95 M

Polar Capital Holdings Plc: 1.83 M

63.84% of Y-mAbs Therapeutics, Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 29.25 M shares in the last 24 months. This purchase volume represents approximately $137.47 M in transactions.